Table 1:

Characteristics of 1,777 women who underwent surgery for stage IIIC or IV ovarian cancer between 1/1/2014 – 12/31/2017

Characteristic	Total (N=1,777)	High risk subgroup (N=501)	Triage appropriate subgroup (N=1,276)
Age (years), mean (SD)	62.6 (11.5)	69.6 (12.2)	59.9 (9.9)
Race/ethnicity
Non-Hispanic White	1246 (70.1)	377 (75.2)	869 (68.1)
Hispanic White	54 (3.0)	11 (2.2)	43 (3.4)
Black or African American	91 (5.1)	28 (5.6)	63 (4.9)
Asian, Native Hawaiian or Pacific Islander	65 (3.7)	10 (2.0)	55 (4.3)
American Indian or Alaska Native	7 (0.4)	2 (0.4)	5 (0.4)
Other or Unknown	314 (17.7)	73 (14.6)	241 (18.9)
Body Mass Index(kg/m2)
<25.0	656 (36.9)	191 (38.1)	465 (36.4)
25.0–39.9	1008 (56.7)	281 (56.1)	727 (57.0)
≥40.0	95 (5.3)	23 (4.6)	72 (5.6)
Not documented	18 (1.0)	6 (1.2)	12 (0.9)
Functional Status
Independent	1765 (99.3)	494 (98.6)	1271 (99.6)
Partially Dependent	10 (0.6)	7 (1.4)	3 (0.2)
Not documented	2 (0.1)	0 (0.0)	2 (0.2)
American Society of Anesthesiologists (ASA) score
<3	597 (33.6)	112 (22.4)	485 (38.0)
≥3	1179 (66.3)	389 (77.6)	790 (61.9)
Not documented	1 (0.1)	0 (0.0)	1 (0.1)
Preoperative albumin (g/dL)
≥3.5	1067 (60.0)	141 (28.1)	926 (72.6)
<3.5	293 (16.5)	293 (58.5)	0 (0.0)
Not documented	417 (23.5)	67 (13.4)	350 (27.4)
FIGO stage
IIIC	1455 (81.9)	412 (82.2)	1043 (81.7)
IV	322 (18.1)	89 (17.8)	233 (18.3)
Surgical complexity
Low	1240 (69.8)	347 (69.3)	893 (70.0)
Intermediate	448 (25.2)	125 (25.0)	323 (25.3)
High	89 (5.0)	29 (5.8)	60 (4.7)
Operative time (minutes), Median (IQR)	192 (135, 263)	180 (129, 255)	195 (140, 266)

Abbreviations: FIGO, International Federation of Gynecology and Obstetrics; SD, standard deviation.

Results are reported as N (%) unless otherwise noted.